ライフサイエンスコーパス: fludeoxyglucose

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ceptance criteria, and testing schedule) for fludeoxyglucose (18)F ((18)F-FDG) injection listed in th

2 in neurodegeneration was assessed by MRI and fludeoxyglucose-18 positron emission tomography ((18)FDG

3 e association study (GWAS) of decline in PCC fludeoxyglucose F 18 ([(18) F] FDG) positron emission to

4 relates with brain metabolism as measured by fludeoxyglucose F 18 ([(18)F]-FDG) positron emission tom

5 ent-naive HIV-infected individuals underwent fludeoxyglucose F 18 ([18F]-FDG) positron emission tomog

6 tron emission tomography (PET) combined with fludeoxyglucose F 18 (FDG) is recommended for the noninv

7 d by positron emission tomography imaging of fludeoxyglucose F 18 and serial prolactin levels.

8 tained by positron emission tomography using fludeoxyglucose F 18 as the tracer.

9 ment for apolipoprotein epsilon4, concurrent fludeoxyglucose F 18 PET scan, and baseline cognitive st

10 Fludeoxyglucose F 18 positron emission tomography was pe

11 omography, AD hypometabolic pattern shown on fludeoxyglucose F 18 positron emission tomography, and/o

12 Cognitive scores, mean fludeoxyglucose F 18 standardized uptake value ratio (pa

13 We used positron emission tomography and fludeoxyglucose F 18 to measure brain metabolism in Viet

14 etabolism (positron emission tomography with fludeoxyglucose F 18), extracted from Alzheimer disease-

15 During uptake of fludeoxyglucose F 18, all patients performed a serial ve

16 ow reduced glucose metabolism, as indexed by fludeoxyglucose F 18-labeled positron emission tomograph

17 of the PET scan was estimated by multiplying fludeoxyglucose F18 radioactivity with dose coefficients

18 [(18)F]Fludeoxyglucose positron emission tomography showed incr

19 Dynamic Contrast-Enhanced MRI (DCE-MRI) and Fludeoxyglucose Positron Emission Tomography(FDG-PET).

20 lorbetapir positron emission tomography, 18F-fludeoxyglucose positron emission tomography, structural

21 tive study was to assess predictive value of fludeoxyglucose-positron emission tomography (FDG-PET) a

22 d no family history of dementia has abnormal fludeoxyglucose-positron emission tomography imaging and

23 This study aimed to determine whether 18F-fludeoxyglucose-positron emission tomography/computed to

24 at is the sensitivity and specificity of 18F-fludeoxyglucose-positron emission tomography/computed to

25 emission tomography with 18F-florbetapir and fludeoxyglucose was used to quantify amyloid retention a

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。